State of Wyoming’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,406
| Closed | -$191K | – | 1623 |
|
|
2024
Q4 | $191K | Buy |
10,406
+4,315
| +71% | +$79.2K | 0.02% | 864 |
|
|
2024
Q3 | $93.7K | Buy |
+6,091
| New | +$93.7K | 0.01% | 1198 |
|
|
2024
Q1 | – | Sell |
-8,033
| Closed | -$252K | – | 1600 |
|
|
2023
Q4 | $252K | Buy |
8,033
+6,554
| +443% | +$205K | 0.05% | 405 |
|
|
2023
Q3 | $30.8K | Sell |
1,479
-3,146
| -68% | -$65.6K | 0.01% | 1408 |
|
|
2023
Q2 | $111K | Buy |
+4,625
| New | +$111K | 0.03% | 781 |
|
|
2023
Q1 | – | Sell |
-5,784
| Closed | -$92.1K | – | 1570 |
|
|
2022
Q4 | $92.1K | Buy |
+5,784
| New | +$92.1K | 0.03% | 815 |
|
|
2022
Q3 | – | Sell |
-5,550
| Closed | -$78K | – | 1493 |
|
|
2022
Q2 | $78K | Sell |
5,550
-6,967
| -56% | -$97.9K | 0.05% | 656 |
|
|
2022
Q1 | $304K | Buy |
12,517
+928
| +8% | +$22.5K | 0.15% | 83 |
|
|
2021
Q4 | $271K | Buy |
11,589
+2,071
| +22% | +$48.4K | 0.13% | 124 |
|
|
2021
Q3 | $158K | Sell |
9,518
-275
| -3% | -$4.57K | 0.1% | 239 |
|
|
2021
Q2 | $239K | Buy |
9,793
+8,139
| +492% | +$199K | 0.15% | 146 |
|
|
2021
Q1 | $43K | Buy |
+1,654
| New | +$43K | 0.07% | 237 |
|